Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
236.12 +1.22 / +0.52%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
236.12 0.00 / 0.00%
 
Volume: 4.2K

Today’s Trading

Previous close234.90
Today’s open232.73
Day’s range232.04 - 236.36
Volume982,983
Average volume (3 months)1,758,017
Market cap$80.1B
Dividend yield--
Data as of 4:01pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+38.91%
Earnings growth (next 5 years)+23.80%
Revenue growth (last year)+43.22%
P/E ratio97.8
Price/Sales5.93
Price/Book14.79

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.06+0.19%
ABTAbbott Laboratories+0.38+0.83%
LLYEli Lilly and Co-0.55-0.66%
CELGCelgene+1.00+0.81%
Data as of 4:05pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$2.71
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts

Partner Offers